ARTICLE | Clinical News
Amphinex: Extension study completed enrollment
June 4, 2012 7:00 AM UTC
PCI Biotech completed enrollment of 3 patients in an extension study of a U.K. Phase I/II trial evaluating IV Amphinex plus bleomycin given at doses below the maximum tolerated dose. The extension stu...